Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Non-Hodgkin | 27 | 2024 | 1376 | 4.480 |
Why?
|
Multiple Myeloma | 28 | 2024 | 5196 | 2.090 |
Why?
|
Trans Fatty Acids | 2 | 2020 | 155 | 1.180 |
Why?
|
HTLV-I Infections | 3 | 2009 | 104 | 0.800 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 6 | 2022 | 1437 | 0.740 |
Why?
|
Hodgkin Disease | 6 | 2024 | 1384 | 0.720 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 438 | 0.650 |
Why?
|
Body Mass Index | 13 | 2024 | 13055 | 0.620 |
Why?
|
Body Size | 3 | 2022 | 463 | 0.600 |
Why?
|
Anthropometry | 4 | 2024 | 1345 | 0.600 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2018 | 190 | 0.570 |
Why?
|
Lymphoma, Follicular | 5 | 2022 | 460 | 0.540 |
Why?
|
Case-Control Studies | 37 | 2024 | 22296 | 0.540 |
Why?
|
Aspirin | 2 | 2021 | 3135 | 0.530 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2023 | 1399 | 0.530 |
Why?
|
Diet | 5 | 2021 | 8088 | 0.520 |
Why?
|
Risk Factors | 49 | 2025 | 74976 | 0.500 |
Why?
|
Prospective Studies | 33 | 2024 | 54962 | 0.490 |
Why?
|
Herpesvirus 4, Human | 6 | 2017 | 1082 | 0.480 |
Why?
|
Nurses | 4 | 2021 | 2501 | 0.460 |
Why?
|
Fatty Acids | 3 | 2023 | 1812 | 0.460 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 2276 | 0.460 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2022 | 1642 | 0.440 |
Why?
|
Epstein-Barr Virus Infections | 4 | 2017 | 617 | 0.430 |
Why?
|
Interleukin-6 | 3 | 2017 | 3232 | 0.430 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2012 | 1943 | 0.420 |
Why?
|
Obesity | 9 | 2024 | 13091 | 0.410 |
Why?
|
Dietary Fats | 2 | 2018 | 2002 | 0.410 |
Why?
|
HIV Seronegativity | 1 | 2013 | 210 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 17 | 2023 | 18068 | 0.390 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 2 | 2011 | 158 | 0.380 |
Why?
|
Endometrial Neoplasms | 2 | 2022 | 1386 | 0.370 |
Why?
|
Follow-Up Studies | 20 | 2024 | 39394 | 0.370 |
Why?
|
Hematologic Neoplasms | 3 | 2024 | 1907 | 0.350 |
Why?
|
Middle Aged | 65 | 2024 | 223737 | 0.340 |
Why?
|
Genome-Wide Association Study | 16 | 2023 | 12801 | 0.330 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2022 | 179 | 0.320 |
Why?
|
Proportional Hazards Models | 10 | 2023 | 12562 | 0.320 |
Why?
|
Adult | 60 | 2024 | 223851 | 0.310 |
Why?
|
Feeding Behavior | 2 | 2017 | 3205 | 0.290 |
Why?
|
Polymorphism, Single Nucleotide | 20 | 2023 | 16053 | 0.280 |
Why?
|
Humans | 105 | 2025 | 768970 | 0.280 |
Why?
|
Aged | 45 | 2024 | 171786 | 0.270 |
Why?
|
Lymphoma, B-Cell | 3 | 2020 | 945 | 0.270 |
Why?
|
Antibodies, Viral | 4 | 2011 | 3215 | 0.270 |
Why?
|
Female | 72 | 2024 | 397515 | 0.270 |
Why?
|
Clone Cells | 3 | 2019 | 1670 | 0.270 |
Why?
|
Male | 66 | 2024 | 365203 | 0.270 |
Why?
|
Neoplasms | 8 | 2025 | 22389 | 0.270 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2020 | 180 | 0.260 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3608 | 0.260 |
Why?
|
Body Height | 3 | 2023 | 1569 | 0.250 |
Why?
|
Young Adult | 24 | 2024 | 60131 | 0.240 |
Why?
|
HTLV-I Antibodies | 1 | 2004 | 35 | 0.240 |
Why?
|
Odds Ratio | 10 | 2020 | 9684 | 0.240 |
Why?
|
Autoimmune Diseases | 4 | 2022 | 2258 | 0.240 |
Why?
|
Ovarian Neoplasms | 3 | 2021 | 4919 | 0.230 |
Why?
|
Hematopoiesis | 3 | 2019 | 2059 | 0.230 |
Why?
|
Tattooing | 1 | 2024 | 57 | 0.230 |
Why?
|
Hepatitis C Antibodies | 1 | 2004 | 151 | 0.230 |
Why?
|
Viral Proteins | 1 | 2011 | 1802 | 0.230 |
Why?
|
Burkitt Lymphoma | 2 | 2018 | 338 | 0.220 |
Why?
|
Chromosomes, Human | 2 | 2017 | 438 | 0.220 |
Why?
|
Carrier State | 1 | 2006 | 529 | 0.200 |
Why?
|
Life Style | 5 | 2016 | 3931 | 0.190 |
Why?
|
Trust | 2 | 2023 | 532 | 0.190 |
Why?
|
Risk | 8 | 2017 | 9621 | 0.190 |
Why?
|
Chemokine CXCL13 | 1 | 2021 | 62 | 0.180 |
Why?
|
Hair Dyes | 1 | 2020 | 30 | 0.180 |
Why?
|
Pesticide Residues | 1 | 2021 | 95 | 0.180 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2022 | 240 | 0.170 |
Why?
|
Cytokines | 2 | 2021 | 7453 | 0.170 |
Why?
|
Exercise | 3 | 2018 | 5954 | 0.160 |
Why?
|
Environmental Exposure | 2 | 2025 | 4544 | 0.160 |
Why?
|
Osteosarcoma | 2 | 2023 | 911 | 0.160 |
Why?
|
Connecticut | 3 | 2015 | 365 | 0.160 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2018 | 23 | 0.160 |
Why?
|
Cohort Studies | 14 | 2024 | 41808 | 0.160 |
Why?
|
Occupational Exposure | 4 | 2018 | 1807 | 0.160 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 323 | 0.160 |
Why?
|
Genetic Variation | 2 | 2016 | 6611 | 0.150 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5443 | 0.150 |
Why?
|
Waist Circumference | 1 | 2022 | 935 | 0.150 |
Why?
|
Pesticides | 1 | 2021 | 298 | 0.150 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1560 | 0.150 |
Why?
|
Menstrual Cycle | 1 | 2022 | 546 | 0.150 |
Why?
|
United States | 16 | 2024 | 73186 | 0.150 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2018 | 286 | 0.150 |
Why?
|
Efficiency | 1 | 2021 | 480 | 0.150 |
Why?
|
Occupational Diseases | 2 | 2018 | 1458 | 0.140 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2018 | 370 | 0.140 |
Why?
|
Solvents | 1 | 2018 | 298 | 0.140 |
Why?
|
Leukemia, Lymphoid | 1 | 2017 | 312 | 0.140 |
Why?
|
Linkage Disequilibrium | 2 | 2020 | 2000 | 0.140 |
Why?
|
Infertility, Female | 1 | 2023 | 764 | 0.140 |
Why?
|
Resistin | 1 | 2017 | 172 | 0.140 |
Why?
|
Adiponectin | 3 | 2018 | 1117 | 0.130 |
Why?
|
Genetic Loci | 3 | 2016 | 2630 | 0.130 |
Why?
|
Incidence | 10 | 2023 | 21547 | 0.130 |
Why?
|
HLA Antigens | 3 | 2019 | 1336 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3253 | 0.130 |
Why?
|
Leukemia | 2 | 2014 | 1520 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2121 | 0.120 |
Why?
|
Adolescent | 20 | 2024 | 89244 | 0.120 |
Why?
|
Multifactorial Inheritance | 2 | 2020 | 1423 | 0.120 |
Why?
|
Mosaicism | 1 | 2018 | 481 | 0.120 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6982 | 0.120 |
Why?
|
Infectious Mononucleosis | 2 | 2012 | 133 | 0.120 |
Why?
|
Fruit | 2 | 2021 | 1165 | 0.120 |
Why?
|
Vegetables | 2 | 2021 | 1199 | 0.120 |
Why?
|
Reproductive History | 1 | 2015 | 210 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2017 | 1183 | 0.110 |
Why?
|
Hepatitis C | 1 | 2004 | 1595 | 0.110 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2018 | 1439 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1473 | 0.110 |
Why?
|
Blood Donors | 1 | 2015 | 344 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 693 | 0.110 |
Why?
|
Cell Membrane | 1 | 2022 | 3659 | 0.110 |
Why?
|
Periodontal Diseases | 1 | 2016 | 455 | 0.110 |
Why?
|
Logistic Models | 4 | 2018 | 13318 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1674 | 0.100 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1738 | 0.100 |
Why?
|
Japan | 2 | 2009 | 1418 | 0.100 |
Why?
|
Antibody Formation | 1 | 2017 | 1393 | 0.100 |
Why?
|
Meat | 1 | 2015 | 588 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2721 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 877 | 0.100 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 251 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2021 | 59739 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1780 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2336 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2018 | 1363 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1904 | 0.090 |
Why?
|
Carbonated Beverages | 1 | 2012 | 210 | 0.090 |
Why?
|
Austria | 2 | 2022 | 209 | 0.090 |
Why?
|
Sex Factors | 5 | 2024 | 10633 | 0.090 |
Why?
|
Survival Analysis | 2 | 2021 | 10115 | 0.090 |
Why?
|
Dietary Sucrose | 1 | 2012 | 242 | 0.090 |
Why?
|
Leisure Activities | 1 | 2012 | 310 | 0.090 |
Why?
|
Models, Genetic | 1 | 2020 | 3449 | 0.090 |
Why?
|
Air Pollutants | 1 | 2024 | 2915 | 0.090 |
Why?
|
Birth Order | 1 | 2010 | 93 | 0.090 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 276 | 0.090 |
Why?
|
Sweetening Agents | 1 | 2012 | 290 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 757 | 0.080 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.080 |
Why?
|
Energy Intake | 1 | 2017 | 2146 | 0.080 |
Why?
|
Haplotypes | 3 | 2014 | 2725 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1077 | 0.080 |
Why?
|
Jamaica | 1 | 2009 | 54 | 0.080 |
Why?
|
Genotype | 6 | 2020 | 13048 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 299 | 0.080 |
Why?
|
Registries | 3 | 2021 | 8384 | 0.080 |
Why?
|
Methionine | 1 | 2011 | 573 | 0.080 |
Why?
|
Massachusetts | 4 | 2019 | 8894 | 0.080 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2009 | 143 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2442 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4363 | 0.080 |
Why?
|
Antigens, Viral | 2 | 2010 | 996 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1886 | 0.070 |
Why?
|
Smoking | 4 | 2023 | 9094 | 0.070 |
Why?
|
Health Personnel | 2 | 2024 | 3383 | 0.070 |
Why?
|
Australia | 3 | 2017 | 1265 | 0.070 |
Why?
|
Sweden | 2 | 2021 | 1382 | 0.070 |
Why?
|
Gene Frequency | 3 | 2020 | 3626 | 0.070 |
Why?
|
Risk Assessment | 4 | 2020 | 24333 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3813 | 0.070 |
Why?
|
Inflammation | 3 | 2024 | 10868 | 0.070 |
Why?
|
HIV Infections | 1 | 2013 | 17591 | 0.070 |
Why?
|
Sex Distribution | 2 | 2019 | 2280 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 2081 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2748 | 0.070 |
Why?
|
Postmenopause | 1 | 2015 | 2519 | 0.070 |
Why?
|
Age Distribution | 2 | 2019 | 2875 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2022 | 4879 | 0.060 |
Why?
|
Immunoglobulin E | 2 | 2017 | 1506 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 1040 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12253 | 0.060 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1344 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4064 | 0.060 |
Why?
|
Utah | 1 | 2024 | 130 | 0.060 |
Why?
|
Receptors, IgE | 1 | 2006 | 375 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8749 | 0.060 |
Why?
|
Overweight | 1 | 2016 | 2448 | 0.060 |
Why?
|
Folic Acid | 1 | 2011 | 1338 | 0.060 |
Why?
|
Prognosis | 5 | 2019 | 30046 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3421 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3713 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7861 | 0.060 |
Why?
|
Tuberculin Test | 1 | 2004 | 205 | 0.060 |
Why?
|
Health Behavior | 1 | 2015 | 2649 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3626 | 0.050 |
Why?
|
Mutation | 2 | 2019 | 30266 | 0.050 |
Why?
|
Fatty Acid Desaturases | 1 | 2023 | 102 | 0.050 |
Why?
|
Europe | 3 | 2014 | 3441 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8094 | 0.050 |
Why?
|
Serologic Tests | 1 | 2004 | 382 | 0.050 |
Why?
|
Alleles | 3 | 2019 | 6901 | 0.050 |
Why?
|
Anti-Asthmatic Agents | 2 | 1996 | 577 | 0.050 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4794 | 0.050 |
Why?
|
Government | 1 | 2022 | 161 | 0.050 |
Why?
|
Intention | 1 | 2024 | 348 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5864 | 0.050 |
Why?
|
North America | 2 | 2014 | 1290 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4045 | 0.040 |
Why?
|
Yogurt | 1 | 2020 | 71 | 0.040 |
Why?
|
NF-kappa B | 1 | 2009 | 2492 | 0.040 |
Why?
|
Quality Control | 1 | 2023 | 836 | 0.040 |
Why?
|
Puberty | 1 | 2023 | 501 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2009 | 1173 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 542 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14794 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3721 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13510 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2133 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14201 | 0.040 |
Why?
|
Chromosome Fragile Sites | 1 | 2018 | 26 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2914 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2004 | 2932 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 2 | 1997 | 347 | 0.040 |
Why?
|
Comorbidity | 3 | 2021 | 10592 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1528 | 0.040 |
Why?
|
Chromosome Breakage | 1 | 2018 | 159 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5505 | 0.040 |
Why?
|
Puerto Rico | 1 | 2019 | 380 | 0.040 |
Why?
|
Meta-Analysis as Topic | 2 | 2015 | 1364 | 0.040 |
Why?
|
Ghana | 1 | 2019 | 333 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2018 | 277 | 0.040 |
Why?
|
Fenoterol | 1 | 1997 | 2 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2565 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2017 | 4625 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2017 | 36 | 0.040 |
Why?
|
Asthma | 4 | 1997 | 6293 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 352 | 0.030 |
Why?
|
Reference Values | 1 | 2004 | 4940 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 643 | 0.030 |
Why?
|
C-Peptide | 1 | 2018 | 443 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 386 | 0.030 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2016 | 55 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2018 | 344 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26395 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 527 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5891 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2019 | 424 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2020 | 2251 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2020 | 682 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3671 | 0.030 |
Why?
|
Health | 1 | 2018 | 398 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12873 | 0.030 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 565 | 0.030 |
Why?
|
Tooth Loss | 1 | 2016 | 200 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15471 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2018 | 1524 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 737 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 246 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 352 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4528 | 0.030 |
Why?
|
Health Maintenance Organizations | 1 | 1996 | 657 | 0.030 |
Why?
|
Causality | 1 | 2020 | 1256 | 0.030 |
Why?
|
Rural Population | 1 | 2004 | 2325 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 472 | 0.030 |
Why?
|
Alveolar Bone Loss | 1 | 2016 | 401 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4628 | 0.030 |
Why?
|
Aspartame | 1 | 2012 | 19 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2067 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20245 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 789 | 0.030 |
Why?
|
Computational Biology | 2 | 2015 | 3562 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11262 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 313 | 0.020 |
Why?
|
American Cancer Society | 1 | 2012 | 69 | 0.020 |
Why?
|
Triglycerides | 1 | 2020 | 2464 | 0.020 |
Why?
|
Bacteria | 1 | 2023 | 2216 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40261 | 0.020 |
Why?
|
Age Factors | 3 | 2018 | 18435 | 0.020 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
Thymidylate Synthase | 1 | 2011 | 74 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2022 | 81903 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4300 | 0.020 |
Why?
|
Ovarian Cysts | 1 | 1992 | 108 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 994 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2798 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10276 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10765 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2913 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1151 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1597 | 0.020 |
Why?
|
Occupations | 1 | 2013 | 516 | 0.020 |
Why?
|
Drug Industry | 1 | 1997 | 793 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2820 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6856 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 1992 | 561 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1575 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1517 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 808 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4290 | 0.020 |
Why?
|
Prevalence | 2 | 2024 | 15879 | 0.020 |
Why?
|
Acute Disease | 2 | 2016 | 7245 | 0.020 |
Why?
|
Animals | 2 | 2020 | 169335 | 0.020 |
Why?
|
Research Design | 1 | 2025 | 6214 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3438 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1526 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5801 | 0.020 |
Why?
|
Carbon | 1 | 2011 | 672 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2680 | 0.020 |
Why?
|
Military Personnel | 1 | 2017 | 1264 | 0.020 |
Why?
|
Family | 1 | 2018 | 3208 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12430 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2771 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2732 | 0.020 |
Why?
|
Capsid Proteins | 1 | 2010 | 468 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2827 | 0.020 |
Why?
|
Anemia, Hemolytic | 1 | 2008 | 164 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2019 | 2063 | 0.020 |
Why?
|
Food | 1 | 2011 | 768 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 828 | 0.020 |
Why?
|
Sjogren's Syndrome | 1 | 2008 | 241 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 2986 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2911 | 0.020 |
Why?
|
Population Surveillance | 1 | 2015 | 2597 | 0.020 |
Why?
|
Insulin | 1 | 2018 | 6610 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6435 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12095 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4356 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13594 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1642 | 0.010 |
Why?
|
Vitamins | 1 | 2011 | 1638 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10486 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3811 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13674 | 0.010 |
Why?
|
Boston | 2 | 2011 | 9377 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2012 | 2649 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3773 | 0.010 |
Why?
|
Celiac Disease | 1 | 2008 | 820 | 0.010 |
Why?
|
Psoriasis | 1 | 2008 | 926 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9618 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7885 | 0.010 |
Why?
|
Child | 3 | 2023 | 80960 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9213 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2576 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5892 | 0.010 |
Why?
|
New Zealand | 1 | 1997 | 360 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 65480 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15661 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2008 | 2171 | 0.010 |
Why?
|
Theophylline | 1 | 1995 | 133 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1169 | 0.010 |
Why?
|
Pharmacoepidemiology | 1 | 1997 | 351 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21188 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 3780 | 0.010 |
Why?
|
Community Health Services | 1 | 1995 | 659 | 0.010 |
Why?
|
Patient Admission | 1 | 1996 | 1370 | 0.010 |
Why?
|
Drug Utilization | 1 | 1995 | 1191 | 0.000 |
Why?
|
Disease Outbreaks | 1 | 1997 | 1761 | 0.000 |
Why?
|
Medical Records | 1 | 1992 | 1411 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1995 | 1892 | 0.000 |
Why?
|
Hospitalization | 2 | 1996 | 10847 | 0.000 |
Why?
|
Child, Preschool | 2 | 1997 | 42683 | 0.000 |
Why?
|
Emergency Medical Services | 1 | 1995 | 1947 | 0.000 |
Why?
|
Intensive Care Units | 1 | 1996 | 3800 | 0.000 |
Why?
|
Drug Prescriptions | 1 | 1992 | 1673 | 0.000 |
Why?
|
Health Care Costs | 1 | 1995 | 3270 | 0.000 |
Why?
|
Infant | 1 | 1996 | 36556 | 0.000 |
Why?
|
Pregnancy | 1 | 1992 | 30265 | 0.000 |
Why?
|